Induction of Cuproptosis with a Highly Cytotoxic Tripodal Cu(II) Complex for Anticancer Therapy
Journal of Medicinal Chemistry · 12.06.2025 · 68 (11) · 12258-12271
DOI: 10.1021/acs.jmedchem.5c01124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 03.06.2025. Verfasst von Ricarda Zimmermann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany. Hauptthemen laut MEDLINE: Copper, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Fonds der Chemischen Industrie, Paul-Ehrlich-Gesellschaft Stiftung, Aventis Foundation.
Abstract (Originalsprache)
Despite the widespread use of chemotherapeutic agents, their reliance on apoptosis often limits therapeutic efficacy and leads to drug resistance. To overcome these challenges, alternative cell death mechanisms such as cuproptosis have gained significant attention. While previous studies have primarily focused on incorporation of Cu into nanostructures, this work presents the first example of a molecular tripodal Cu(II) complex as a potent cuproptosis inducer. Herein, a series of tripodal Cu(II) complexes were chemically synthesized and biologically evaluated. The most promising compound demonstrated remarkable cytotoxicity in the low micromolar to nanomolar range. Mechanistic studies revealed that the compound catalytically produced hydroxyl radicals in the mitochondria of cancerous cells, causing protein oligomerization and the disruption of iron-sulfur cluster proteins, ultimately triggering cell death by cuproptosis. Contrary to traditional chemotherapeutic agents that cause reduction in tumor size, this compound induced the fragmentation of three-dimensional tumor spheroids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany.
ORCID-Profile: Johannes Karges
Förderung
- Fonds der Chemischen Industrie
- Paul-Ehrlich-Gesellschaft Stiftung
- Aventis Foundation
Zitieren
APA
Zimmermann, R., Montesdeoca, N., & Karges, J. (2025). Induction of Cuproptosis with a Highly Cytotoxic Tripodal Cu(II) Complex for Anticancer Therapy. Journal of Medicinal Chemistry, 68(11), 12258-12271. https://doi.org/10.1021/acs.jmedchem.5c01124
Vancouver
Zimmermann R, Montesdeoca N, Karges J. Induction of Cuproptosis with a Highly Cytotoxic Tripodal Cu(II) Complex for Anticancer Therapy. Journal of Medicinal Chemistry. 2025;68(11):12258-12271. doi:10.1021/acs.jmedchem.5c01124
BibTeX
@article{Zimmermann2025,
author = {Zimmermann, Ricarda and Montesdeoca, Nicolás and Karges, Johannes},
title = {Induction of Cuproptosis with a Highly Cytotoxic Tripodal Cu(II) Complex for Anticancer Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {11},
pages = {12258--12271},
doi = {10.1021/acs.jmedchem.5c01124}
}
EUVIMED